ESC 365 - Genetics to identify new drug targets in atrial fibrillation.

ESC Premium Access

Genetics to identify new drug targets in atrial fibrillation.

Session: Horizons of discovery: using genetics to identify new drug targets

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor D. Dobrev (Essen, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)

11 presentations

2 followers

3 more presentations in this session

Genetics to identify new drug targets in ischaemic heart disease.

Speaker: Doctor T. Kessler (Munich, DE)

Genetics to identify new drug targets in stroke.

Speaker: Professor M. Dichgans (Munich, DE)

Genetics to identify new drug targets in cardiomyopathy.

Speaker: Doctor A. Marian (Houston, US)

Access the full session

Horizons of discovery: using genetics to identify new drug targets

Speakers: Professor D. Dobrev, Doctor T. Kessler, Professor M. Dichgans, Doctor A. Marian

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources